Skip to main content
. 2015 Apr 2;2015(4):CD006037. doi: 10.1002/14651858.CD006037.pub3

Comparison 4. MIB vs. control: maternal outcomes.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Positive urine drug test (end of treatment) 2 278 Risk Ratio (M‐H, Random, 95% CI) 0.96 [0.63, 1.48]
2 Positive urine drug test at three months (follow‐up) 1 159 Risk Ratio (M‐H, Random, 95% CI) 1.13 [0.55, 2.31]
3 Positive urine at delivery 1 128 Risk Ratio (M‐H, Random, 95% CI) 0.84 [0.57, 1.24]
4 Retention at treatment completion 3 355 Risk Ratio (M‐H, Random, 95% CI) 0.97 [0.89, 1.06]
5 Short term treatment retention 3 334 Risk Ratio (M‐H, Random, 95% CI) 0.99 [0.88, 1.12]